IT-system Development for Reaching Cervix Cancer Screening Non-attenders
IT-system Development for Individualization of Cervix Cancer Screening and Implementation of New Strategies to Reach Non-attenders
Sponsor: Karolinska Institutet
This NA trial investigates Cervical Cancer and Human Papillomavirus DNA Tests and is currently ongoing. Karolinska Institutet leads this study, which shows 8 recorded versions since 2016 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Nov 2022 — Jul 2024 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
-
Jan 2021 — Nov 2022 [monthly]
Active Not Recruiting NA
-
Oct 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
Status: Unknown Status → Active Not Recruiting · Phase: PHASE2_PHASE3 → NA
▶ Show 3 earlier versions
-
Jun 2018 — Oct 2020 [monthly]
Unknown Status PHASE2_PHASE3
-
May 2018 — Jun 2018 [monthly]
Unknown Status PHASE2_PHASE3
Status: Enrolling By Invitation → Unknown Status
-
Jan 2017 — May 2018 [monthly]
Enrolling By Invitation PHASE2_PHASE3
First recorded
Mar 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Karolinska Institutet
- Regional Cancer Centre Stockholm Gotland
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.